Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells

International Journal of Cancer

Volumn 94, Issue 2, 2001, Pages 282-289

  Shirakawa, Toshiro ^a,b   Sasaki, Ryohei ^a   Gardner, Thomas A ^a   Kao, Chinghai ^a   Zhang, Zhu Jun ^a   Sugimura, Kazuro ^a   Matsuo, Masafumi ^a   Kamidono, Sadao ^a   Gotoh, Akinobu ^a  

^a KOBE UNIVERSITY   (Japan)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Bladder cancer; Drug resistance; Gene therapy; Gene transfer; p53

Indexed keywords

CISPLATIN; DOXORUBICIN; MESSENGER RNA; PROTEIN BAX; PROTEIN P21; PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; BLADDER CANCER; CELL CYCLE G1 PHASE; CELL KILLING; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOVIRIDAE; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; DRUG RESISTANCE, NEOPLASM; EXONS; G1 PHASE; GENE THERAPY; GENES, P53; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, VIRUS; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0035888245     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1453     Document Type: Article

References (34)

1. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium
2. Biochemistry of multidrug resistance mediated by multidrug transporter
3. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model
4. Gene therapy: Principles and potential
5. In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug
6. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene
7. Effects of a recombinant adenovirus expressing WAF1/CIP1 on cell growth, cell cycle and apoptosis
8. 1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy
9. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma
10. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression
11. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: A gene therapy approach for drug-resistant cancers
12. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM
13. Enhanced expression of γ-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistant phenotype
14. Allelotype of breast cancer: Cumulative allele losses promote tumor progression in primary breast cancer
15. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
16. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis
17. Evidence that the protein base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor
18. Methods for construction of adenovirus vectors
19. Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system
20. Real-time quantitative polymerase chain reaction to assess gene transfer
21. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
22. Accumulation of nuclear p53 and tumor progression in bladder cancer
23. p53 adenovirus-mediated gene transfer in bladder cancer
24. Gene therapy for bladder cancer
25. 5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma
26. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays
27. Adenoviral DNA integration and changes in DNA methylation patterns: A different view of insertional mutagenesis
28. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain
29. A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor
30. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
31. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
32. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer
33. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation
34. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vector